大健康业务
Search documents
悦心健康:预计2025年归属于上市公司股东的净利润750万元~1100万元
Mei Ri Jing Ji Xin Wen· 2026-01-29 08:32
每经头条(nbdtoutiao)——水贝黄金平台"杰我睿"兑付危机调查:40倍杠杆对赌,金价越涨平台越 亏!老板自称"还在深圳",投资者:兑付方案本金打两折,无法接受 (记者 曾健辉) 每经AI快讯,悦心健康1月29日晚间发布业绩预告,预计2025年归属于上市公司股东的净利润750万元 ~1100万元,比上年同期增长105.10%~107.48%,基本每股收益0.0081元~0.0119元。业绩变动主要原因 是,本报告期大健康业务收入较上年增长约15.5%。本报告期各类资产减值损失预计比上年减少约7876 万元。本报告期瓷砖业务受市场竞争加剧影响销售量同比下降约6%,销售收入同比下降约15.7%,受瓷 砖业务销售收入下降影响,四项费用比上年下降约4100万元。本报告期所得税费用预计比上年减少约 3389万元。 ...
国药现代:李显林辞去公司副总裁等职务
Mei Ri Jing Ji Xin Wen· 2025-08-04 04:27
Group 1 - The core point of the article is the resignation of Mr. Li Xianlin from his position as Vice President of China National Pharmaceutical Group Modern (国药现代) due to reaching retirement age, and he will not hold any positions in the company or its subsidiaries after his departure [2]. Group 2 - For the fiscal year 2024, the revenue composition of China National Pharmaceutical Group Modern is as follows: formulations account for 49.84%, intermediates and active pharmaceutical ingredients account for 47.53%, other businesses account for 2.44%, and health-related businesses account for 0.19% [2].